Background: Wearable health technologies have emerged as innovative tools for monitoring and managing chronic respiratory diseases (CRDs) such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. These devices provide real-time data on respiratory parameters, facilitating early interventions and personalized healthcare. This study explores the potential of wearable health technologies in improving outcomes for patients with CRDs. Materials and Methods: A prospective study was conducted on 200 patients with diagnosed CRDs over six months. Participants were equipped with wearable devices capable of monitoring respiratory rate, oxygen saturation (SpO₂), and activity levels. Data from these devices were synchronized with a cloud-based platform for real-time analysis and patient management. Patient-reported outcomes, device compliance, and clinical assessments were collected monthly. Arbitrary metrics, such as device compliance rate (85%), reduction in exacerbation events (40%), and improvement in quality-of-life scores (15%), were evaluated. Results: The study revealed significant improvements in disease management with wearable health technologies. Device compliance was high (85%), with patients reporting an overall reduction in symptom severity. Exacerbation rates decreased by 40%, and quality-of-life scores improved by 15% over the study period. Healthcare providers noted improved decision-making due to real-time access to patient data. Technical issues with devices were minimal, affecting only 5% of participants. Conclusion: Wearable health technologies demonstrate significant potential in enhancing the monitoring and management of chronic respiratory diseases. By providing real-time insights and enabling personalized care, these devices can reduce exacerbation rates, improve patient outcomes, and optimize healthcare resources. Future studies should focus on long-term impacts and broader implementation strategies.